Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Tim Sullivan"'
Publikováno v:
Animal Behavior and Cognition, Vol 2, Iss 3, Pp 233-240 (2015)
The maintenance of species-specific behaviors for animals in zoological institutions is of top priority, as this can help ensure high levels of animal welfare. Strict feeding schedules within institutions can often impact natural foraging behaviors o
Externí odkaz:
https://doaj.org/article/090c4db891bc42b48efddcfcc105abc5
Autor:
Mayte Suárez-Fariñas, Robert Arbeit, Weiwen Jiang, Francesca S Ortenzio, Tim Sullivan, James G Krueger
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e84634 (2013)
Psoriasis is a complex inflammatory disease resulting from the activation of T helper (Th) 1 and Th17 cells. Recent evidence suggests that abnormal activation of Toll-like receptors (TLRs) 7, 8 and 9 contributes to the initiation and maintenance of p
Externí odkaz:
https://doaj.org/article/d7a33dca48934c1ca953e632e69731aa
Autor:
Noam Angrist, Claire Cullen, Micheal Ainomugisha, Sai Pramod Bathena, Peter Bergman, Colin Crossley, Thato Letsomo, Moitshepi Matsheng, Rene Marlon Panti, Shwetlena Sabarwal, Tim Sullivan
Publikováno v:
AEA Papers and Proceedings. 113:482-488
We present detailed monitoring data across a five-country randomized trial of phone-based targeted tutoring–one of the largest multicountry replication efforts in education to date. We study an approach shown to work in Botswana and replicated in I
Publikováno v:
Bulletin of the New Zealand Society for Earthquake Engineering. 56:11-28
The Ministry of Building, Innovation and Employment is developing advice on how to deliver Low Damage Seismic Design (LDSD) protection for buildings through their Tū Kahika: Building Resilience platform. The draft LDSD advice is considering a design
Publikováno v:
Pharmaceutical Medicine. 36:215-222
Causality assessment of safety signals observed with medicinal products is a foundational element of pharmacovigilance and regulatory practice, typically performed by a global introspection process. We have developed a novel, structured methodologica
Autor:
Noam Angrist, Micheal Ainomugisha, Sai Pramod Bathena, Peter Bergman, Colin Crossley, Claire Cullen, Thato Letsomo, Moitshepi Matsheng, Rene Marlon Panti, Shwetlena Sabarwal, Tim Sullivan
Education systems need to withstand frequent shocks, including conflict, disease, natural dis-asters, and climate events, all of which routinely close schools. During these emergencies, alternative models are needed to deliver education. However, rig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7076226056f5ac5c11c7829f033ba4
https://ora.ox.ac.uk/objects/uuid:69fcd858-e1a4-4e68-8686-92a277e4190b
https://ora.ox.ac.uk/objects/uuid:69fcd858-e1a4-4e68-8686-92a277e4190b
Autor:
Jordon Tourville, Michael Zarfos, Gregory Lawrence, Todd McDonnell, Tim Sullivan, Martin Dovciak
Aims Climate change is expected to shift climatic envelopes of temperate tree species into boreal forests where unsuitable soils may limit range expansion. We studied several edaphic thresholds (mycorrhizae, soil chemistry) that can limit seedling es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bd5c7094df92d6c3100430b4dacdb36
https://doi.org/10.21203/rs.3.rs-2761587/v1
https://doi.org/10.21203/rs.3.rs-2761587/v1
Publikováno v:
Therapeutic Innovation & Regulatory Science.
Robust and transparent formal benefit-risk (BR) analyses for medicinal products represent a means to better understand the appropriate use of medicinal products, and to maximize their value to prescribers and patients. Despite regulatory and social i
Publikováno v:
The Structural Engineer. 100:26-33
This paper describes the key design and construction challenges of the Compton and Edrich stands – two striking additions to Lord’s Cricket Ground in London. The new stands increase the capacity of the ground and bring new sponsor boxes and other
Publikováno v:
The International Journal of Risk & Safety in Medicine
BACKGROUND: In 2012, Patient Safety (PS) in AstraZeneca was facing a situation with multiple challenges, scientifically and structurally. OBJECTIVE: To meet these and support AstraZeneca’s ambition to return to growth after years of patent expiry,